Abstract
The results of 44 studies investigating financial impact and return on investment (ROI) from disease management (DM) programs for asthma, congestive heart failure (CHF), diabetes, depression, and multiple illnesses were examined. A positive ROI was found for programs directed at CHF and multiple disease conditions. Some evidence suggests that diabetes programs may save more than they cost, but additional studies are needed. Results are mixed for asthma management programs. Depression management programs cost more than they save in medical expenses, but may save money when considering productivity outcomes.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1-19 |
| Number of pages | 19 |
| Journal | Health Care Financing Review |
| Volume | 26 |
| Issue number | 4 |
| State | Published - Jun 2005 |
| Externally published | Yes |
Fingerprint
ASJC Scopus subject areas
- Nursing(all)
- Health(social science)
- Health Professions(all)
Cite this
Return on investment in disease management : A review. / Goetzel, Ronnie; Ozminkowski, Ronald J.; Villagra, Victor G.; Duffy, Jennifer.
In: Health Care Financing Review, Vol. 26, No. 4, 06.2005, p. 1-19.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Return on investment in disease management
T2 - A review
AU - Goetzel, Ronnie
AU - Ozminkowski, Ronald J.
AU - Villagra, Victor G.
AU - Duffy, Jennifer
PY - 2005/6
Y1 - 2005/6
N2 - The results of 44 studies investigating financial impact and return on investment (ROI) from disease management (DM) programs for asthma, congestive heart failure (CHF), diabetes, depression, and multiple illnesses were examined. A positive ROI was found for programs directed at CHF and multiple disease conditions. Some evidence suggests that diabetes programs may save more than they cost, but additional studies are needed. Results are mixed for asthma management programs. Depression management programs cost more than they save in medical expenses, but may save money when considering productivity outcomes.
AB - The results of 44 studies investigating financial impact and return on investment (ROI) from disease management (DM) programs for asthma, congestive heart failure (CHF), diabetes, depression, and multiple illnesses were examined. A positive ROI was found for programs directed at CHF and multiple disease conditions. Some evidence suggests that diabetes programs may save more than they cost, but additional studies are needed. Results are mixed for asthma management programs. Depression management programs cost more than they save in medical expenses, but may save money when considering productivity outcomes.
UR - http://www.scopus.com/inward/record.url?scp=24144442442&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=24144442442&partnerID=8YFLogxK
M3 - Article
C2 - 17288065
AN - SCOPUS:24144442442
VL - 26
SP - 1
EP - 19
JO - Health Care Financing Review
JF - Health Care Financing Review
SN - 2159-0354
IS - 4
ER -